Literature DB >> 3029073

The molecular basis of a familial apoE deficiency. An acceptor splice site mutation in the third intron of the deficient apoE gene.

C Cladaras, M Hadzopoulou-Cladaras, B K Felber, G Pavlakis, V I Zannis.   

Abstract

The molecular basis of the familial apoE deficiency was investigated by gene cloning and comparative expression studies of the normal and the deficient apoE gene. For the latter studies the apoE genes were placed under the control of the mouse metallothionein I promoter in a bovine papilloma virus vector. The studies showed that in the normal gene the mouse metallothionein I promoter directs the synthesis of normal apoE mRNA and protein. In contrast, in the deficient apoE gene the same promoter directs the synthesis of two abnormal apoE mRNA forms, which are similar to those observed in the peripheral blood monocyte macrophage cultures of the patient. Restriction analysis of the cloned gene and partial DNA sequence has shown an A to G substitution in the penultimate 3' nucleotide of the third intron of the apoE gene. This single base substitution abolishes the correct 3' splice site thus creating two abnormally spliced mRNA forms. The smaller form contains 53 nucleotides and the larger form contains the entire third intron of the apoE gene. Both of these mRNA species contain chain termination codons within the intronic sequence and code for short apoE peptides that are not detectable by gel electrophoretic techniques. These findings show that this form of familial apoE deficiency results from a point mutation in the 3' splice junction of the third intron of the apoE gene. Furthermore, the expression system we have employed to study apoE deficiency can be utilized to analyze a broad spectrum of genetic diseases associated with mRNA processing mutations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029073

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Genetic basis of lipoprotein disorders.

Authors:  J L Breslow
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

Review 2.  Inflammasomes and metabolic disorders: old genes in modern diseases.

Authors:  Gregory R Robbins; Haitao Wen; Jenny P-Y Ting
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

3.  Mutations in the unc-52 gene responsible for body wall muscle defects in adult Caenorhabditis elegans are located in alternatively spliced exons.

Authors:  T M Rogalski; E J Gilchrist; G P Mullen; D G Moerman
Journal:  Genetics       Date:  1995-01       Impact factor: 4.562

4.  Severe xanthomatosis associated with familial apolipoprotein E deficiency.

Authors:  G Feussner
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

5.  The CpG dinucleotide and human genetic disease.

Authors:  D N Cooper; H Youssoufian
Journal:  Hum Genet       Date:  1988-02       Impact factor: 4.132

6.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.

Authors:  J A Piedrahita; S H Zhang; J R Hagaman; P M Oliver; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

7.  ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  J Lipid Res       Date:  2016-03-25       Impact factor: 5.922

8.  Splicing mutation in human hereditary analbuminemia.

Authors:  D E Ruffner; A Dugaiczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

9.  Macrophage-specific up-regulation of apolipoprotein E gene expression by STAT1 is achieved via long range genomic interactions.

Authors:  Violeta Georgeta Trusca; Elena Valeria Fuior; Irina Cristina Florea; Dimitris Kardassis; Maya Simionescu; Anca Violeta Gafencu
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

10.  Identification of a splice-site mutation in the aldolase B gene from an individual with hereditary fructose intolerance.

Authors:  C C Brooks; N Buist; J Tuerck; D R Tolan
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.